Exhibit 16.1

 

January 25, 2021

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

Commissioners:

We have read the statements made by Northwest Biotherapeutics, Inc. under Item 4.01 of its Form 8-K dated January 21, 2021. We agree with the statements concerning our Firm in such Form 8-K; we are not in a position to agree or disagree with other statements of Northwest Biotherapeutics, Inc. contained therein.

Very truly yours,